Immune Design Corp.
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Immune Design Corp. generated cash of -$51,666,000, which is more than the previous year. Cash used in financing activities reached the amount of $228,000 last year. Net change in cash is therefore -$713,000.

Cash Flow

Immune Design Corp. (NASDAQ:IMDZ): Cash Flow
2014 -20.66M -344K 65.98M
2015 -37.80M -427K 75.79M
2016 -35.74M -62.42M 30.45M
2017 -53.05M -7.03M 87.33M
2018 -51.66M 50.92M 228K

IMDZ Cash Flow Statement (2014 – 2018)

2018 2017 2016 2015 2014
Cash at beginning of period
78.65M45.21M112.92M75.35M30.38M
Operating activities
Net income
-54.75M-51.86M-53.53M-39.44M-34.15M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
907K377K178K243K238K
Stock-based compensation expense
7.27M8.63M9.28M6.29M1.34M
Deferred income tax benefit 7.27M8.63M9.28M6.29M1.34M
Changes in operating assets and liabilities:
Accounts receivable, net
-58K-130K455K998K-1.88M
Inventories
-652K-77K-594K12K-8K
Accounts payable
-856K-2.22M1.48M-3.82M6.03M
Cash generated by operating activities
-51.66M-53.05M-35.74M-37.80M-20.66M
Investing activities
Purchases Of Investments
-34.68M-71.61M-102.28M00
Investments In Property Plant And Equipment
-390K-428K-133K-427K-344K
Acquisitions Net
00000
Cash generated by investing activities
50.92M-7.03M-62.42M-427K-344K
Financing activities
Common Stock Issued
228K86.62M30.31M75.35M57.80M
Payments for dividends
00000
Repurchases of common stock
-77.94M-72.45M-45.21M-112.92M-75.35M
Repayments of term debt
00000
Cash used in financing activities
228K87.33M30.45M75.79M65.98M
Net Change In Cash
-713K27.24M-67.70M37.56M44.96M
Cash at end of period
77.94M72.45M45.21M112.92M75.35M
Data sourceData sourceData sourceData sourceData source